Effects of MHRA drug safety advice on time trends in prescribing volume and indices of clinical toxicity for quinine

British Journal of Clinical Pharmacology

Volumn 76, Issue 6, 2013, Pages 973-979

  Acheampong, Paul ^a   Cooper, Gill ^b   Khazaeli, Behshad ^a   Lupton, David J ^c   White, Sue ^a   May, Margaret T ^d   Thomas, Simon H L ^a,e  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

adverse effects; overdose; prescribing; quinine; safety; toxicity

Indexed keywords

QUININE;

ACIDOSIS; ARTICLE; BEHAVIOR DISORDER; CARDIOTOXICITY; COMA; CONVULSION; DRUG FATALITY; DRUG INTOXICATION; DRUG SAFETY; HEARING IMPAIRMENT; HUMAN; HYPOGLYCEMIA; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STUPOR; TELEPHONE; THERAPEUTIC ERROR; VISUAL IMPAIRMENT;

ADVERSE EFFECTS; OVERDOSE; PRESCRIBING; QUININE; SAFETY; TOXICITY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CLINICAL MEDICINE; DATABASES, PHARMACEUTICAL; DRUG PRESCRIPTIONS; ENGLAND; LEGISLATION, DRUG; MUSCLE RELAXANTS, CENTRAL; PRACTICE GUIDELINES AS TOPIC; QUININE; TIME FACTORS;

EID: 84888044934     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12130     Document Type: Article

References (16)

1. Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA,; HPA Advisory Committee on Malaria Prevention in UK Travellers. UK malaria treatment guidelines. J Infect 2007; 54: 111-121.
2. Man-Son-Hing M, Wells G, Lau A,. Quinine for nocturnal leg cramps: a meta-analysis including unpublished data. J Gen Intern Med 1998; 13: 600-606.
3. Jansen PH, Veenhuizen KC, Wesseling AI, de Boo T, Verbeek AL,. Randomised controlled trial of hydroquinine in muscle cramps. Lancet 1997; 349: 528-532.
4. Diener HC, Dethlefsen U, Dethlefsen-Gruber S, Verbeek P,. Effectiveness of quinine in treating muscle cramps: a double-blind, placebo-controlled, parallel-group, multicentre trial. Int J Clin Pract 2002; 56: 243-246.
5. Benowitz NL,. Poisoning and Overdose., Olson KR, editor. 6th edn. San Francisco, California: McGraw-Hill, 2011; 358-359.
6. Bateman DN, Blain PG, Woodhouse KW, Rawlins MD, Dyson H, Heyworth R, Prescott LF, Proudfoot AT,. Pharmacokinetics and clinical toxicity of quinine overdosage: lack of efficacy of techniques intended to enhance elimination. Q J Med 1985; 54: 125-131.
7. Langford NJ, Good AM, Laing WJ, Bateman DN,. Quinine intoxications reported to the Scottish Poisons Information Bureau 1997-2002: a continuing problem. Br J Clin Pharmacol 2003; 56: 576-578.
8. Winek CL, Davis ER, Collom WD, Shanor SP,. Quinine fatality-case report. Clin Toxicol 1974; 7: 129-132.
9. Food and Drug Administration, Department of Health and Human Services. Drug products containing quinine; enforcement action dates. Fed Regist 2006; 71: 75557-75560.
10. Tilstone C,. Quinine: not to be used routinely for nocturnal leg cramps. Drug Saf Update 2010; 3: 3-4.
11. Kim HJ, Fay MP, Feuer EJ, Midthune DN,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351. (correction: 2001;20:655).
12. Anonymous, Directive 2010/84/EU of the European Parliament and of the Council, 15 December 2010-amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use. 2010. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L: 2010:348:0074:0099:EN:PDF (last accessed 29 January 2013).
13. Waring WS, McGettigan P,. Clinical toxicology and drug regulation: a United Kingdom perspective. Clin Toxicol 2011; 49: 452-456.
14. Bergen H, Hawton K, Murphy E, Cooper J, Kapur N, Stalker C, Waters K,. Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds. Br J Clin Pharmacol 2009; 68: 618-629.
15. Poon H, Elliot V, Bateman DN, Waring WS,. Impact of legislative changes on patterns of antipsychotic prescribing and self-poisoning in Scotland: 2000-06. J Toxicol Sci 2007; 32: 1-7.
16. Sandilands EA, Bateman DN,. Co-proxamol withdrawal has reduced suicide from drugs in Scotland. Br J Clin Pharmacol 2008; 66: 290-293.